Biocon gets zero UFSDA observations for Hyderabad facility Ruchika Sharma22 May 2023 12:12 PM ISTBangalore: Biocon has announced that the US Food and Drug Administration (USFDA) has completed a pre-approval inspection at the...
Biocon Biologics-Edelweiss deal cleared by CCI Ruchika Sharma11 May 2023 12:30 PM ISTThe deal has been cleared under the green channel route.
Biocon Biologics Bengaluru facility gets EU GMP certification for Bevacizumab Ruchika Sharma29 April 2023 11:47 AM ISTBangalore: Biocon Biologics’ integrated, multi-product, monoclonal antibodies (mAbs) Drug Substance manufacturing facility (B3) at Biocon Park,...
Serum Institute of Life Sciences to double investment in Biocon unit to Rs 2457 crore Ruchika Sharma25 April 2023 12:30 PM ISTUnder new terms of the alliance, it would pump in USD 150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd,...
Biocon Academy conducts Graduation Ceremony for 185 students across four programs Ruchika Sharma9 April 2023 1:00 PM ISTEight outstanding students who topped their respective batches were awarded 'Gold Medals for Academic Excellence'.
Biocon Biologics bags 'ABEA : Bioprocessing Excellence in South Asia' Award Ruchika Sharma28 March 2023 4:15 PM ISTBiocon Biologics was recognized as the winner as it garnered the maximum number of votes from among 70,000 biopharma professionals who participated in...
Biocon raises Rs 1067 crore from Kotak to fund biosimilars deal Ruchika Sharma23 Feb 2023 1:00 PM IST"This investment in Biocon comes at a pivotal point when Biocon is forward integrating its biosimilars business," Srini Sriniwasan, managing director...
Biocon recalls over 3000 bottles of antifungal drug Posaconazole Delayed Release in US Ruchika Sharma19 Feb 2023 11:15 AM ISTNew Delhi: Biotechnology major Biocon is recalling 3,665 bottles of antifungal medication in the US market for "failed degradation specifications",...
Biocon Q3FY23 revenue at Rs 3,020 crore, up 36 percent MD Bureau15 Feb 2023 11:15 AM IST"We reported a strong EBITDA growth of 35 percent to Rs 723 crore, representing a healthy EBITDA margin of 24 percent. Core EBITDA grew 49 percent to...
Biocon partner Viatris gets Complete Response Letter from USFDA for Bevacizumab license application Ruchika Sharma13 Feb 2023 11:13 AM ISTBevacizumab is a medication used to treat a number of types of cancers and a specific eye disease.
Inclusive and growth-oriented budget: Biocon Chief Kiran Mazumdar-Shaw Ruchika Sharma2 Feb 2023 3:15 PM ISTWelcoming the introduction of a new programme for research and innovation in pharma through centres of excellence, Kiran Mazumdar-Shaw said it would...
Biocon CSR arm wins 'IHW Gold Award for Diseases Screening Initiative of the Year' for 2022 Ruchika Sharma25 Jan 2023 10:00 AM ISTBengaluru: Biocon Foundation, the Corporate Social Responsibility (CSR) arm of Biocon Limited, has been awarded the Gold Award in the ‘Diseases...
